• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nature . Lung dendritic-cell metabolism underlies susceptibility to viral infection in diabetes

tetano

Editor, Senior Moderator
Nature


. 2023 Dec 13.
doi: 10.1038/s41586-023-06803-0. Online ahead of print. Lung dendritic-cell metabolism underlies susceptibility to viral infection in diabetes

Samuel Philip Nobs[SUP] #[/SUP][SUP] 1 [/SUP], Aleksandra A Kolodziejczyk[SUP] #[/SUP][SUP] 1 2 [/SUP], Lital Adler[SUP] 3 [/SUP], Nir Horesh[SUP] 1 4 5 [/SUP], Christine Botscharnikow[SUP] 1 [/SUP], Ella Herzog[SUP] 1 [/SUP], Gayatree Mohapatra[SUP] 1 [/SUP], Sophia Hejndorf[SUP] 1 [/SUP], Ryan-James Hodgetts[SUP] 1 [/SUP], Igor Spivak[SUP] 1 [/SUP], Lena Schorr[SUP] 6 7 [/SUP], Leviel Fluhr[SUP] 1 [/SUP], Denise Kviatcovsky[SUP] 1 [/SUP], Anish Zacharia[SUP] 8 [/SUP], Suzanne Njuki[SUP] 8 [/SUP], Dinorah Barasch[SUP] 8 [/SUP], Noa Stettner[SUP] 9 [/SUP], Mally Dori-Bachash[SUP] 1 [/SUP], Alon Harmelin[SUP] 9 [/SUP], Alexander Brandis[SUP] 10 [/SUP], Tevie Mehlman[SUP] 10 [/SUP], Ayelet Erez[SUP] 3 [/SUP], Yiming He[SUP] 1 [/SUP], Sara Ferrini[SUP] 1 [/SUP], Jens Puschhof[SUP] 6 [/SUP], Hagit Shapiro[SUP] 1 [/SUP], Manfred Kopf[SUP] 11 [/SUP], Arieh Moussaieff[SUP] 8 [/SUP], Suhaib K Abdeen[SUP] 12 [/SUP], Eran Elinav[SUP] 13 14 [/SUP]



Affiliations
Abstract

People with diabetes feature a life-risking susceptibility to respiratory viral infection, including influenza and SARS-CoV-2 (ref. [SUP]1[/SUP]), whose mechanism remains unknown. In acquired and genetic mouse models of diabetes, induced with an acute pulmonary viral infection, we demonstrate that hyperglycaemia leads to impaired costimulatory molecule expression, antigen transport and T cell priming in distinct lung dendritic cell (DC) subsets, driving a defective antiviral adaptive immune response, delayed viral clearance and enhanced mortality. Mechanistically, hyperglycaemia induces an altered metabolic DC circuitry characterized by increased glucose-to-acetyl-CoA shunting and downstream histone acetylation, leading to global chromatin alterations. These, in turn, drive impaired expression of key DC effectors including central antigen presentation-related genes. Either glucose-lowering treatment or pharmacological modulation of histone acetylation rescues DC function and antiviral immunity. Collectively, we highlight a hyperglycaemia-driven metabolic-immune axis orchestrating DC dysfunction during pulmonary viral infection and identify metabolic checkpoints that may be therapeutically exploited in mitigating exacerbated disease in infected diabetics.


 
Back
Top Bottom